Time To Upgrade Merus N.V. To A 'Buy' After The Recent Selloff
Merus is a buy with Bizengri approval for NRG1+ cancers, Petosemtamab's potential, and partnership with BHVN for oncology ...
The Australian Financial Review20h
Perpetual Limited
Portfolio management, financial planning, trustee, responsible entity and compliance services, executor services, investment administration and custody services.